Legal & General Group
PTX

Legal & General Group’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Legal & General Group’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-573
Closed -$6K – 2954
2016
Q1 		$6K Hold
573
– – ﹤0.01% 2766
2015
Q4 		$16K Hold
573
– – ﹤0.01% 2731
2015
Q3 		$17K Hold
573
– – ﹤0.01% 2742
2015
Q2 		$33K Hold
573
– – ﹤0.01% 2671
2015
Q1 		$60K Hold
573
– – ﹤0.01% 2402
2014
Q4 		$54K Hold
573
– – ﹤0.01% 2396
2014
Q3 		$44K Buy
+573
New +$45.1K ﹤0.01% 2465

Other funds holding PTX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Legal & General Group's PTX Position: Q2 2016 in Review

Legal & General Group sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q2 2016, closing a stake of 573 shares — an estimated $6K sold.

Legal & General Group first reported a position in PTX in Q3 2014 and held it in 7 quarters. The position peaked at $60K in Q1 2015. 56 funds tracked by Wall St. Rank hold PTX as of Q2 2016.

  • Legal & General Group reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q2 2016 after selling out during the quarter.
  • Legal & General Group sold 573 Pernix Therapeutics Holdings, Inc. shares in Q2 2016, an estimated $6K.
  • Legal & General Group first reported a position in Pernix Therapeutics Holdings, Inc. in Q3 2014 and held it in 7 quarters.
  • Legal & General Group's Pernix Therapeutics Holdings, Inc. position peaked at $60K in Q1 2015.
  • 56 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q2 2016.

Based on Legal & General Group's 13F filing for Q2 2016, filed 16 Aug 2016.